Skip to main content
SpringerLink
Log in

A Case of Myasthenia Gravis with Two Primary Tumors: Paraneoplastic or Incidental?

  • Case Report
  • Published:
Journal of Gastrointestinal Cancer Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2

Availability of Data and Materials

Not applicable.

References

  1. Nagtegaal ID, Odze RD, Klimstra D, et al. The 2019 WHO classification of tumours of the digestive system. Histopathology. 2020;76:182–8.

    Article  Google Scholar 

  2. Pavel M, Öberg K, Falconi M, et al. Gastroenteropancreatic neuroendocrine neoplasms: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up. Ann Oncol. 2020;31:844–60.

    Article  CAS  Google Scholar 

  3. Gorelik M, Ahmad M, Grossman D, et al. Nonfunctioning incidental pancreatic neuroendocrine tumors: who, when, and how to treat? Surgical Clinics. 2018;98:157–67.

    PubMed  Google Scholar 

  4. Melzer N, Ruck T, Fuhr P, et al. Clinical features, pathogenesis, and treatment of myasthenia gravis: a supplement to the Guidelines of the German Neurological Society. J Neurol. 2016;263:1473–94.

    Article  CAS  Google Scholar 

  5. Ro C, Chai W, Victoria EY, et al. Pancreatic neuroendocrine tumors: biology, diagnosis, and treatment. Chin J Cancer. 2013;32:312.

    Article  CAS  Google Scholar 

  6. Halfdanarson TR, Bamlet WR, McWilliams RR, et al. Risk factors for pancreatic neuroendocrine tumors (PNETs): a clinic-based case-control study. Pancreas. 2014;43:1219.

    Article  CAS  Google Scholar 

  7. Kamath GR, Kim MK, Taioli E. Risk of primary neuroendocrine pancreatic tumor following a first primary cancer: a US population-based study. Pancreas. 2019;48:161.

    Article  Google Scholar 

  8. Skeie G, Romi F. Paraneoplastic myasthenia gravis: immunological and clinical aspects. Eur J Neurol. 2008;15:1029–33.

    Article  CAS  Google Scholar 

  9. Ito T, Igarashi H, Jensen RT. Pancreatic neuroendocrine tumors: clinical features, diagnosis and medical treatment: advances. Best Pract Res Clin Gastroenterol. 2012;26:737–53.

    Article  Google Scholar 

  10. Lu T, Song B, Pu H, et al. Paraneoplastic pemphigus and myasthenia gravis as the first manifestations of a rare case of pancreatic follicular dendritic cell sarcoma: CT findings and review of literature. BMC Gastroenterol. 2019;19:1–7.

    Article  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Internal Medicine, Gazi University, Ankara, Turkey

    Tuba Uğur

  2. Department of Medical Oncology, Gazi University, Besevler/Ankara, Turkey

    Fatih Gürler & Ahmet Özet

  3. Department of Neurology, Gazi University, Ankara, Turkey

    Bülent Cengiz & Reha Kuruoğlu

Authors
  1. Tuba Uğur
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Fatih Gürler
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Bülent Cengiz
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Reha Kuruoğlu
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Ahmet Özet
    View author publications

    You can also search for this author in PubMed Google Scholar

Contributions

All authors contributed to the study conception and design. Material preparation, data collection, and analysis were performed by Tuba Uğur, Fatih Gürler, Bülent Cengiz, Reha Kuruoğlu, and Ahmet Özet. The first draft of the manuscript was written by Tuba Uğur and Fatih Gürler, and all authors commented on previous versions of the manuscript. All authors read and approved the final manuscript.

Corresponding author

Correspondence to Fatih Gürler.

Ethics declarations

Ethics Approval and Consent to Participate

Ethics approval is not applicable. Informed consent of the patient was obtained.

Consent for Publication

Informed consent for publication was obtained.

Competing Interests

The authors declare no competing interests.

Additional information

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Uğur, T., Gürler, F., Cengiz, B. et al. A Case of Myasthenia Gravis with Two Primary Tumors: Paraneoplastic or Incidental?. J Gastrointest Canc 53, 837–840 (2022). https://doi.org/10.1007/s12029-021-00702-1

Download citation

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s12029-021-00702-1

Search

Navigation